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Commentary
Oncogene Activation in Experimental
Carcinogenesis: The Role of Carcinogen
and Tissue Specificity
by Seymour J. Garte* and Anne E. Hochwalt*
Techniques of molecular biology have been used to determine the relationship of cellular oncogenes to
mechanisms ofexperimental carcinogenesis. Model systems involving three direct-acting alkylating carcino-
gens, two organ sites, and two species have been employed to elucidate the relationships between carcino-
genic etiology, tissue specificity, and activation ofknown and novel oncogenes. Dimethylcarbamyl chloride,
a reactive acylating agent, induces tumors ofboth the rat nasal mucosa and mouse skin whose DNA is de-
voidofNIH 3T3transformingactivity. P-propiolactone-induced ratnasal carcinomas contain anovel oncogene,
6 to 9 kb in size, whereas a mouse skin carcinoma induced by this agent possesses an H-ras oncogene acti-
vated by a 61st codon A to T transversion mutation. The novel oncogene activated in rat nasal tumors in-
duced by P-propiolactone is distinct from one found in methylmethane sulfonate-induced tumors. The im-
plications ofthese findings forunderstanding how oncogenes fit into general mechanism ofcarcinogenesis
are discussed.
Introduction
Research into experimental carcinogenesis has pro-
vided majorinsights related to the biology of cancer since
the beginning of the century. This field of research has
always been quick to adapt concepts and technologies
from other areas of biomedical research in order to ad-
vance understanding ofthe carcinogenic process in lab-
oratory animals and humans. The most recent example
is the use of molecular biology to address some of the
most basic questions concerning the mechanisms by
which normal cells can be altered to express the malig-
nant phenotype. Earlier work in experimental tumor
virology demonstrating the existence oftransforming on-
cogenes (1) has been extended more recently to discov-
eries of cellular oncogenes and their activation by en-
vironmental carcinogens, such as radiation and chemicals
(2).
The concept that all cancers induced by viral, chemical,
orphysical agents, as well as those due to genetic suscep-
tibility, orofspontaneous origin share a commonpathway
involving activation of a specific set ofgenes is an attrac-
tive idea forthe unification offormerly diverse mechanis-
tic theories. Verification ofthis hypothesis requires evi-
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dence that cellular oncogenes are in fact targets for
environmental carcinogens. Moreover, the data from re-
search into cellular oncogene activation must be cor-
related with the wealthofbiological andbiochemical data
amassed from experimental cancer research during the
past decades. Several laboratories have successfully ap-
proached these critical issues.
In the context oftwo-stage carinogenesis, Balmain and
co-workers have shown that activation of H-ras is an
early event, probably coincidental withthe initiation step
(3). Furthermore, this group has found that an active
H-ras gene can serve as an initiator invivo in the mouse
skin system (4). We have found evidence that ras gene
transformation of NIH 3T3 cells in vitro may also be a
multistage process and that events analogous to promo-
tion are required for complete transformation even after
transfection with a purified, active oncogene (5).
Barbacid and his colleagues (6,7) have convincingly
demonstrated mutational activation of the H-ras on-
cogene in a manner consistent with the predicted chem-
ical reactivity of the carcinogens used to produce rat
mammary tumors. Otherlaboratories have explored the
influences ofcarcinogen andmouse strain ononcogene ac-
tivation in murine lymphomas (8,9) and compared pat-
terns of activating ras mutations in spontaneous and
chemically induced mouse liver tumors (10).
We have been investigating the issues of carcinogen
and tissue specificity in experimental carcinogenesis us-
ing direct-acting alkylating agents (11). This class of
chemical carcinogens does not require metabolic activa-30 GARTE AND HOCHWALT
tion, andgenerally produces tumors in diverse tissues of
several species. The carcinogens P-propiolactone (BPL),
methylmethane sulfonate (MMS), and dimethylcarbamyl
chloride (DMCC) produce squamous cell carcinomas of
the rat nasal mucosa after inhalation (12) and in mouse
skin after topical administration.
Results and Discussion
None ofthe rat nasal carcinomas induced by any agent
contained activated ras oncogenes, although DNAsfrom
many ofthe BPL- and MMS-induced tumors were posi-
tive in the NIH 3T3 transfectionfocus assay. In contrast,
none ofthe DMCC-induced tumors contained DNA with
NIH 3T3 transforming activity. It appearedinitially that
BPL and MMS, which are both SN2 alkylating agents,
mightbeactivating acommononcogene. Thehighlyreac-
tive acylating agent DMCC produces a different pattern
ofDNA adducts according to an SNi reactionmechanism
(13,14). By the technique of comparing restriction en-
donuclease sensitivity patterns ofthe transformingactiv-
ity from these tumors, we found that a common novel on-
cogene was activated in the BPL-induced tumors.
However, this gene was distinct from another novel on-
cogene reproducibly activated in the MMS-induced
tumors. Further characterization of the activated gene
from BPL-induced tumors indicated its size to be be-
tween 6 and 9 kb (15). This was determined using trans-
formant DNA originally derivedfrom a BPL-induced tu-
mor, digested with Pst 1 (an enzyme previously shown
not to alter the gene's transforming activity). The
digested DNA was separated on a preparative agarose
gel andpurified size fractions were used in atransfection
experiment. Only the fraction migratingto the region on
the gel corresponding to the 6- to 9-kb range possessed
transforming activity. We have begun further rounds of
transfection using a ligated, selectable marker in order
to clone and further characterize this novel oncogene.
The carcinogen specificity in oncogene activation dem-
onstrated by BPL-, MMS-, and DMCC-induced rat nasal
carcinomas is strengthened by the data from DMCC-
induced mouse skin carcinomas andfibrosarcomas. As in
the ratnasalmodel, none ofthe more than20 mouse skin
carcinomas or fibrosarcomas induced by DMCC con-
tained DNA with any transforming activity in the NIH
3T3 focus assay. This highly carcinogen-specific effect of
DMCC is the first report ofconsistently negative DNAs
from tumors ofdiverse tissues and speciesinducedby the
same agent. As opposed to our experience with DMCC,
the role tissue specificity in oncogene activation is illus-
trated by our results using BPL-induced tumors. As dis-
cussed earlier, a novel oncogene of6 to 9 kb in size was
consistently activated in BPL-induced rat nasal carci-
nomas. However, inthemouse skinmodel, one oftwo car-
cinomas examined contained an activated H-ras oncogene
(11). Thisgene provedtobe activated by a codon 61 Ato
T transversion mutation (15), as has beenfound in other
mouse skin tumors induced by aromatic hydrocarbons
(16,12). Thus, in the case of BPL, as with other carcino-
gens such as N-methylnitrosourea (7), but in contrast to
DMCC, tissue specificity appears to play a dominant role
in the determination of the identity and mechanisms of
activation of cellular oncogenes.
The implications ofthis research are that activation of
any single particular oncogene is not sufficient to produce
atransformed cell andthat several tissue-specific events
must occurfortransformation toproceed. This conclusion
is consistent with data accumulated during years ofre-
search into the biology ofcarcinogenesis. A useful work-
ing hypothesis is that the nature of the oncogene(s) in-
volved with cellular transformation is a function ofboth
tissue and carcinogen specificity, andthatalternative sets
orpathways ofoncogenes may contribute to transforma-
tion to varying degrees depending on cell type and iden-
tity of the carcinogen used.
A model based on the probabilities ofparticulargenes
being activated in specific cell types, and the impact of
carcinogens on these probabilities has been developed
(18). Future efforts at elucidation of the molecular
parameters ofmechanisms of experimental carcinogen-
esis involving oncogene activation, as well as other
related events, willvery likely leadultimately to adeeper
understanding ofthe commonpathways associated with
cancer induction in experimental animals, as well as in
man.
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